A review showed lifestyle intervention was linked to a 24% reduction in type 2 diabetes (T2D) incidence among women with prior gestational diabetes, compared with standard of care.
Current published evidence suggests lifestyle interventions can help reduce the risk of type 2 diabetes (T2D) in women with prior gestational diabetes (GDM), according to a review published in Diabetes, Obesity and Metabolism.
However, the authors emphasized this review’s findings should be interpreted with caution due to documented publication bias.
Lifestyle interventions such as dietary changes and physical activity have been shown to reduce likelihood of progression to T2D in patients at high-risk, such as those with pre-diabetes. Another high-risk population is women with prior GDM, who are 7 times more likely to develop T2D compared with women without GDM.
“This risk of developing T2DM is greatest within the first decade after the pregnancy in which GDM was diagnosed,” the authors said. “Accordingly, women with recent GDM could benefit from intervention to reduce their risk of progression to T2DM.”
To assess this, the authors conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) published between January 1, 1950, and December 14, 2022. The review included 3745 women across 13 eligible studies that compared lifestyle intervention with standard of care in women with prior GDM.
Eligible studies included RCTs conducted in women with prior GDM, studies comparing lifestyle interventions—including any intensive dietary advice, physical activity advice, or both—with standard of care, and studies reporting T2D incidence during follow-up.
Studies were excluded if lifestyle interventions lasted less than 3 months, if there was no control group, and if they were retrospective or observational in design.
According to a pooled analysis of these 13 studies, lifestyle intervention was linked to a 24% reduction in T2D incidence compared with standard of care (relative risk [RR], 0.76; 95% CI, 0.63-0.93).
A sensitivity analysis including 6 studies that applied similar intensive lifestyle modification as the study intervention demonstrated a positive impact of lifestyle on diabetes prevention (RR, 0.54; 95% CI, 0.38-0.78; I2 34.2%).
Meta-regression analyses also showed the duration of lifestyle intervention (P = .81) and baseline body mass index (P = .90) had no impact on reduced T2D incidence. The pooled analysis also highlighted evidence of publication bias on funnel plot and Egger Test (P = .048). The authors added that the trim-and-fill computation, which adjusted the estimates for this publication bias, did not affect the results of the meta-analysis.
“However, there are nuances to recognize in the interpretation of these data, including the modest degree of risk reduction and limitations inherent within the trials comprising this literature to date,” the authors noted. “In this context, measured interpretation of these findings suggests that lifestyle intervention alone may not be sufficient for effective diabetes prevention in this high-risk patient population in practice.”
Reference
Retnakaran M, Viana LV, Kramer CK. Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. Published online January 3, 2023. doi:10.1111/dom.14966
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
What We’re Reading: ChatGPT in Health Care; Menthol Ban Meeting; Health System Cyberattack Impact
November 30th 2023ChatGPT is changing health care while also raising questions about artificial intelligence's promises and limitations; 24 Biden officials met with the National Organization of Black Law Enforcement Executives to discuss the FDA’s proposal to ban menthol cigarettes; a recent hospital cyberattack shows how the vulnerability of health care systems can put patients at risk.
Read More
7-Day Dosing of Azacytidine Shows Benefit for Females With High-Risk MDS Not Seen in Males
November 30th 2023Investigators from several medical centers in Japan were surprised to find that women with myelodysplastic syndrome (MDS) had a survival advantage from a 7-day dosing schedule, but that benefit compared with a reduced schedule was not seen in men.
Read More